Infliximab and adalimumab drug levels in Crohn's disease: contrasting associations with disease activity and influencing factors
M. G. Ward; B. Warner; N. Unsworth; S.‐W. Chuah; C. Brownclarke; S. Shieh; M. Parkes; J. D. Sanderson; Z. Arkir; J. Reynolds; P. R. Gibson; P. M. Irving
Author Information: Department of Gastroenterology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.